Sort
23,748 grants matching “melanoma”
The Oncogene Activated Mitochondrial Unfolded Protein Response Regulates Senescence Biology
$628,593Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Development of First-in-Class RIPK1 Degraders to Improve Cancer Immunotherapies
$628,386Jin Wang · Baylor College Of Medicine · R01 · FY2025 · CA
Genome-wide mutational integration for ultra-sensitive plasma tumor burden monitoring in immunotherapy
$628,307Dan Landau · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention
$628,206Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2021 · CA
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
$627,949Patrick Alexander Ott · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
$627,949Patrick Alexander Ott · Dana-Farber Cancer Inst · R01 · FY2018 · CA
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
$627,949Patrick Alexander Ott · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Dissecting neoepitope-specific clonal T cell populations in advanced melanoma patients vaccinated with personal neoantigen peptides partnered with local and systemic immune checkpoint Inhibition
$627,949Patrick Alexander Ott · Dana-Farber Cancer Inst · R01 · FY2021 · CA
Defining and Modeling Resistance to RAF/MEK Inhibition in Human Melanoma
$627,899Levi Alexander Garraway · Massachusetts General Hospital · P01 · FY2016 · CA
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
$627,894Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2021 · CA
VERMONT INBRE: LEAD INSTITUTION CORE
$627,617Judith L Van Houten · University Of Vermont & St Agric College · P20 · FY2010 · RR
Optimizing Theranostic Dosimetry and Kidney Biomarkers for Alpha-Emitter Radioligand Therapy in Neuroendocrine Tumors
$627,573Diana Zepeda-Orozco · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · CA
Targeting KLF2 in macrophages to improve immune checkpoint therapy for hepatocellular cancer
$627,562Guangfu Li · University Of Connecticut Sch Of Med/Dnt · R01 · FY2025 · CA
CD4+ T cells and neoantigens in melanoma immunotherapy.
$627,467Rongfu Wang · University Of Southern California · R01 · FY2022 · CA
CD4+ T cells and neoantigens in melanoma immunotherapy.
$627,467Rongfu Wang · University Of Southern California · R01 · FY2023 · CA
iC9-CAR.CSPG4 CAR-T Cells for Head and Neck Squamous Cell Carcinoma
$627,456Jared Weiss · Univ Of North Carolina Chapel Hill · R01 · FY2025 · CA
The Genetics of Ocular Melanoma
$627,386Anne Mary Bowcock · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
A Dose Expansion Study of SX-682 Alone and in Combination with Decitabine in MDS Patients
$627,270Aaron D Schuler · Syntrix Biosystems, Inc. · R44 · FY2025 · CA
Role of Gut Microbiota in Modulating Immune Checkpoint Inhibitory Therapy for Cancer
$627,098Andrew Y Koh · Ut Southwestern Medical Center · R01 · FY2019 · CA
Multimeric Ligands for Targeting Melanoma
$626,904Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA
Molecular Predictive Testing in Ocular Melanoma
$626,898Zelia Maria Correa · University Of Miami School Of Medicine · R01 · FY2021 · CA
Fiber bundle-based divided-pupil confocal endoscope
$626,835Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2012 · CA
Strategies for Distinguishing Success in Immunotherapy Treatments (PQ20)
$626,768James R. Heath · California Institute Of Technology · R01 · FY2015 · CA
Retinoic Acid Induced Lymphangiogenesis for Post-surgical Lymphedema
$626,724Alex K. Wong · Beckman Research Institute/City Of Hope · R01 · FY2022 · HL
Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors
$626,637Hazel B Nichols · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA